Advertisement
News
Subscribe to MDT Magazine News

Bruker 2Q profit rises 75 pct on higher revenue

July 28, 2010 2:45 pm | by The Associated Press | Comments

Shares of Bruker Corp. rose Wednesday after the maker of scientific instruments reported a 75 percent increase in second-quarter profits as revenue climbed.The company earned $22.6 million, or 14 cents per share, compared with $12.9 million, or 8 cents per share, in the same period a year...

Best hope for saving Arctic sea ice is cutting soot emissions, says Stanford researcher

July 28, 2010 2:43 pm | by EurekAlert | Comments

(Stanford University) Soot from the burning of fossil fuels and solid biofuels contributes far more to global warming than has been thought, according to a new Stanford study. But, unlike carbon dioxide, soot lingers only a few weeks in the atmosphere, so cutting emissions could...

TOPICS:

Huntington's disease discovery provides new hope for treatment

July 28, 2010 2:43 pm | by EurekAlert | Comments

(University of Melbourne) Australian scientists have identified the behavior of the mutant protein "huntingtin" which leads to the fatal Huntington's disease providing potential targets to treat the disease, a University of Melbourne study reveals.

TOPICS:
Advertisement

Current list of MAK and BAT values presented with 61 modifications and new entries

July 28, 2010 2:43 pm | by EurekAlert | Comments

(Deutsche Forschungsgemeinschaft) The Deutsche Forschungsgemeinschaft Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the...

TOPICS:

Express Scripts 2Q net income rises 50 percent

July 28, 2010 1:45 pm | by The Associated Press | Comments

Pharmacy-benefits manager Express Scripts Inc. said Wednesday its second-quarter profit rose 50 percent as revenue soared from new business generated by its NextRx unit.In April 2009, the company bought WellPoint's pharmacy benefit management business NextRx for about $4.68 billion. Pharmacy...

Waters Corp. 2Q profit rises 21 percent

July 28, 2010 1:45 pm | by The Associated Press | Comments

Waters Corp., a maker of scientific instruments, on Wednesday said second-quarter profit increased by 21 percent as revenue rose, partly on demand for new products.The company earned $84.9 million, or 90 cents per share, compared with $69.9 million, or 72 cents per share, in the same period a...

Spectranetics posts profit in 2Q

July 28, 2010 1:45 pm | by The Associated Press | Comments

Medical device maker Spectranetics Corp.. turned in a profit in the second quarter as operating expenses dipped.Spectranetics recorded net income of $91,000, or no cents per share, in the quarter ended June 30. That compares with a loss of $2.3 million, or 7 cents per share, during the same...

FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q & A with Michael Klein, Ph.D.

July 28, 2010 12:34 pm | by Bio-Medicine.Org | Comments

SILVER SPRING, Md. , July 28 /PRNewswire-USNewswire/ -- Dr. Michael Klein , director of the Food and Drug Administration (FDA) Controlled Substance Staff, discusses how FDA works with other entities to confront and to prevent misuse and abuse of prescription drugs.   (Logo:...

TOPICS:
Advertisement

New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government

July 28, 2010 12:34 pm | by Bio-Medicine.Org | Comments

WASHINGTON , July 28 /PRNewswire-USNewswire/ -- In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements , Joy Sturm , Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how...

TOPICS:

U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent

July 28, 2010 12:34 pm | by Bio-Medicine.Org | Comments

INDIANAPOLIS , July 28 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid. "We strongly...

TOPICS:

Boston Scientific launches intracranial stent

July 28, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Medical device manufacturer Boston Scientific Corp. today said that it has launched U.S. and European sales of its Neuroform EZ Stent System.

TOPICS:

Molecular mechanism triggering Parkinson's disease identified in Stanford study

July 28, 2010 11:35 am | by EurekAlert | Comments

(Stanford University Medical Center) Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's disease. This discovery not only may explain how a genetic mutation linked to...

TOPICS:

FDA panel recommends Medtronic spinal implant

July 28, 2010 10:45 am | by The Associated Press | Comments

A Food and Drug Administration advisory panel has recommended clearance for Medtronic's spin implant Amplify.The FDA's Orthopedic and Rehabilitation Devices Panel vote 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients. The FDA normally follows the advice of...

TOPICS:

URI researchers utilize new test for transplants

July 28, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Researchers at the University of Rhode Island are working with new mass spectrometry technology to develop a saliva-based test to monitor immunosuppressant drugs used in connection with organ transplants.

TOPICS:

Leap forward in efforts to develop treatments for Huntington's disease

July 28, 2010 9:37 am | by EurekAlert | Comments

(Buck Institute for Age Research) Research reveals that an enzyme linked with multiple disorders -- including stroke, cancer and rheumatoid arthritis -- is also involved in the generation of toxic protein fragments in Huntington's disease.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading